Cargando…

A robust reporting system for measurement of SARS-CoV-2 spike fusion efficiency

Detalles Bibliográficos
Autores principales:	Huang, Cong, Yang, Yang, Yang, Peng, Wang, Fei, Li, Xinyu, Song, Xiang, Wang, Yiming, Yu, Cuiyun, Wang, Xuejun, Wang, Shengqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169031/ https://www.ncbi.nlm.nih.gov/pubmed/35668066 http://dx.doi.org/10.1038/s41392-022-01037-4

Ejemplares similares

An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
por: Yang, Peng, et al.
Publicado: (2021)

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
por: Xia, Shuai, et al.
Publicado: (2020)

An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2
por: Sang, Ye, et al.
Publicado: (2022)

Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity
por: Jiang, Xiaoyi, et al.
Publicado: (2020)

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
por: Wang, Pengfei, et al.
Publicado: (2020)

Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Study of fusion peptide release for the spike protein of SARS-CoV-2
por: Yu, Jie, et al.
Publicado: (2023)

Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants
por: Xing, Xiaorui, et al.
Publicado: (2022)

Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
por: Chen, Xuenian, et al.
Publicado: (2022)

Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant
por: Yuan, Shu, et al.
Publicado: (2022)

Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner
por: Wang, Xin, et al.
Publicado: (2023)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

SARS-CoV-2 spike protein interacts with and activates TLR41
por: Zhao, Yingchi, et al.
Publicado: (2021)

Cryo-EM structure of the SARS-CoV-2 Omicron spike
por: Cerutti, Gabriele, et al.
Publicado: (2022)

New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq
por: Chen, Mengyuan, et al.
Publicado: (2022)

Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes
por: Liu, Yang, et al.
Publicado: (2022)

SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike–mediated cell-to-cell fusion
por: Zhang, Yu-Yuan, et al.
Publicado: (2022)

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
por: Ma, Huabin, et al.
Publicado: (2021)

Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
por: Zhang, Bao-zhong, et al.
Publicado: (2020)

SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
por: Halford, Sarah, et al.
Publicado: (2021)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
por: Yang, Ge, et al.
Publicado: (2021)

Prediction of 30-Day Mortality Using the Quick Pitt Bacteremia Score in Hospitalized Patients with Klebsiella pneumoniae Infection [Letter]
por: Yang, Huiyan, et al.
Publicado: (2023)

Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
por: Navaratnarajah, Chanakha K., et al.
Publicado: (2021)

SARS‐CoV‐2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice
por: Ma, Yao, et al.
Publicado: (2022)

SARS‐CoV‐2 spike protein aggregation is triggered by bacterial lipopolysaccharide
por: Petrlova, Jitka, et al.
Publicado: (2022)

O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule
por: Tian, Wenmin, et al.
Publicado: (2021)

Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein
por: Yang, Chan, et al.
Publicado: (2020)

Ozone Water Is an Effective Disinfectant for SARS-CoV-2
por: Hu, Xiao, et al.
Publicado: (2021)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

SARS‐CoV‐2 spike protein alleviates atherosclerosis by suppressing macrophage lipid uptake through regulating R‐loop formation on MSR1 mRNA
por: Zhao, Wenting, et al.
Publicado: (2021)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

Robust Measurement-Driven Cardinality Balance Multi-Target Multi-Bernoulli Filter
por: Yang, Biao, et al.
Publicado: (2021)

Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein
por: Niort, Kristina, et al.
Publicado: (2023)

Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2
por: Yan, Renhong, et al.
Publicado: (2021)

A protective AAV vaccine for SARS-CoV-2
por: Zhao, Simeng, et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
por: Xu, Shiqi, et al.
Publicado: (2022)

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
por: Fan, Xiaoyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0mse8e8np0qq2i435fevnfq67b